We defined change in blood pressure as standing minus sitting blood pressure, so that a negative number indicated a drop in blood pressure.
Vital signs, sitting blood pressure, heart rate (Blood pressure monitor, Model 711, Omron, UK), respiratory rate and tympanic temperature (Tympanic thermometer, Model 2090, IVAC Corporation, San Diego, CA, USA) were recorded.
Interestingly, in overweight and obese patients with hypertension, MK-0916 athehe same dose had no significant effect on the primary endpoint of sitting blood pressure, but modestly improved other blood pressure endpoints [ 24].
Seventeen participants lacked information on resting blood pressure in the OH test and the mean value of three sitting blood pressure assessments were imputed.
Briefly, in order to enter the trial participants had to be aged 80 or over at the time of randomisation, have a systolic blood pressure of > = 160mmHg and <200mmHg sitting and > = 140mmHg standing with a sitting diastolic pressure of <110mmHg.
Compared to sitting blood pressure at the start of the safety phase, there was a maximal mean systolic blood pressure decrement of 10 mmHg on standing at 1 hour (7.3%) (p = 0.001), accompanied by significant compensatory increases in heart rate at 0 hours (mean increase 6.2 ± 8.0 beats per minute, p = 0.001) and 0.5 hours (3.8 ± 7.5 beats per minute, p = 0.027) (Tables 2 and 3).
Methods: Height, weight, and sitting blood pressure were recorded on 92 female subjects with A. nigricans.
Since sitting increases pressure on the discs in the lower back, I recommend avoiding prolonged sitting or driving.
Methods: Height, weight, and sitting blood pressure were recorded on 184 female subjects with AN and without AN.
